Serious antimicrobial resistance status of pathogens causing hospital-acquired lower respiratory tract infections in north China

Journal of International Medical Research

Volumn 37, Issue 3, 2009, Pages 899-907

  Wang, Yibing ^a   Zhang, R ^b   Li, W ^a   Feng, Y ^a   Leng, T ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG MEDICAL COLLEGE   (China)

Author keywords

Antibiotics; Antimicrobial resistance; Hospital acquired infections; Lower respiratory tract infections

Indexed keywords

AMIKACIN; AMPICILLIN; CEFAZOLIN; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; OFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHINA; DISEASE SURVEILLANCE; DRUG SENSITIVITY; ESCHERICHIA COLI; FUNGUS ISOLATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; PSEUDOMONAS AERUGINOSA; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; CROSS INFECTION; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; RESPIRATORY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; CHINA; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; RESPIRATORY TRACT INFECTIONS;

EID: 70349241763     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700336     Document Type: Article

References (24)

1. Grossman RF, Rotschafer JC, Tan JS: Antimicrobial treatment of lower respiratory tract infections in the hospital setting. Am J Med 2005; 118(suppl 7A): 29S-38S.
2. American Thoracic Society, Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416. (Pubitemid 40227463)
3. Cheng A, Ren N, Wen X, et al: A nosocomial infection point-prevalence survey: results and analysis of 193 Hospitals in China in 2001. Chin J Nosocomiol 2002; 12: 561-563.
4. Bartlett JG, Dowell SF, Mandell LA, et al: Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000; 31: 347-382.
5. Niederman MS, McCombs JS, Unger AN, et al: Treatment cost of acute exacerbations of chronic bronchitis. Clin Ther 1999; 21: 576-591. (Pubitemid 29198043)
6. Gonzales R, Malone DC, Maselli JH, et al: Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001; 33: 757-762. (Pubitemid 32831830)
7. Cosgrove SE: The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006; 42(suppl 2): S82-S89.
8. Paladino JA, Sunderlin JL, Price CS, et al: Economic consequences of antimicrobial resistance. Surg Infect (Larchmt) 2002; 3: 259-267.
9. Felmingham D, Grüneberg RN: The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 2000; 45: 191-203.
10. Ministry of Health of The People's Republic of China: Standard of Antibiotics Susceptibility Test (Kirby-Bauer Method). WS/T125-1999. Beijing: Standards Press of China, 1999.
11. Hsueh PR, Chen WH, Luha KT: Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int J Antimicrob Agents 2005; 26: 463-472.
12. Kohlenberg A, Schwab F, Geffers C, et al: Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between 2000 and 2005. Clin Microbiol Infect 2008; 14: 93-96.
13. Hoban DJ, Biedenbach DJ, Mutnick AH, et al: Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000). Diagn Microbiol Infect Dis 2003; 45: 279-285.
14. Goto H, Takeda H, Kawai S, et al: Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2003). Jpn J Antibiot 2005; 58: 326-358 [in Japanese]. (Pubitemid 37362874)
15. Gales AC, Sader HS, Jones RN: Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis 2002; 44: 301-311. (Pubitemid 35454105)
16. Dorobǎţ OM, Moisoiu A, Tǎlǎpan D: Incidence and resistance patterns of pathogens from lower respiratory tract infections (LRTI). Pneumologia 2007; 56: 7-15 [in Romanian].
17. Lockhart SR, Abramson MA, Beekmann SE, et al: Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol 2007; 45: 3352-3359.
18. Li A: Burns, 1st edn. Shanghai: Shanghai Science and Technology Press, 2001; p 71.
19. Mandell LA, Bartlett JG, Dowell SF, et al: Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003; 37: 1405-1433. (Pubitemid 37494668)
20. Wegener HC: The consequences for food safety of the use of fluoroquinolones in food animals. N Engl J Med 1999; 340: 1581-1582. (Pubitemid 29228189)
21. Peña C, Albareda JM, Pallares R, et al: Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections. Antimicrob Agents Chemother 1995; 39: 520-524.
22. Gotfried MH: Epidemiology of clinically diagnosed community-acquired pneumonia in the primary care setting: results from the 1999-2000 respiratory surveillance program. Am J Med 2001; 111(suppl 9A): 25S-29S; discussion 36S-38S.
23. Lundstrom TS, Sobel JD: Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid. Infect Dis Clin North Am 2000; 14: 463-474. (Pubitemid 30308106)
24. Sievert DM, Rudrik JT, Patel JB, et al: Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis 2008; 46: 668-674.